Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Brain O2 reserve in sickle cell disease.

Literature DB >> 31147375

Brain O₂ reserve in sickle cell disease.

John C Wood¹.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 2019 PMID： 31147375 PMCID： PMC6543519 DOI： 10.1182/blood-2019-04-901124

Source DB: PubMed Journal: Blood ISSN： 0006-4971 Impact factor: 22.113

× No keyword cloud information.

10 in total

1. Red cell exchange transfusions lower cerebral blood flow and oxygen extraction fraction in pediatric sickle cell anemia.

Authors: Kristin P Guilliams; Melanie E Fields; Dustin K Ragan; Cihat Eldeniz; Michael M Binkley; Yasheng Chen; Liam S Comiskey; Allan Doctor; Monica L Hulbert; Joshua S Shimony; Katie D Vo; Robert C McKinstry; Hongyu An; Jin-Moo Lee; Andria L Ford
Journal: Blood Date: 2017-12-18 Impact factor: 22.113

2. Automated oxyhemoglobin dissociation curve construction to assess sickle cell anemia therapy.

Authors: R C Young; R E Rachal; M Del Pilar Aguinaga; B L Nelson; B C Kim; W P Winter; O Castro
Journal: J Natl Med Assoc Date: 2000-09 Impact factor: 1.798

3. White matter has impaired resting oxygen delivery in sickle cell patients.

Authors: Yaqiong Chai; Adam M Bush; Julie Coloigner; Aart J Nederveen; Benita Tamrazi; Chau Vu; Soyoung Choi; Thomas D Coates; Natasha Lepore; John C Wood
Journal: Am J Hematol Date: 2019-02-21 Impact factor: 10.047

4. Increased brain tissue oxygenation during arteriovenous malformation resection.

Authors: F T Charbel; W E Hoffman; M Misra; J I Ausman
Journal: Neurol Med Chir (Tokyo) Date: 1998 Impact factor: 1.742

5. Hypoxic regulation of the cerebral microcirculation is mediated by a carbon monoxide-sensitive hydrogen sulfide pathway.

Authors: Takayuki Morikawa; Mayumi Kajimura; Tomomi Nakamura; Takako Hishiki; Tsuyoshi Nakanishi; Yoshinori Yukutake; Yoshiko Nagahata; Mami Ishikawa; Katsuji Hattori; Toshiki Takenouchi; Takao Takahashi; Isao Ishii; Kazuko Matsubara; Yasuaki Kabe; Shinichiro Uchiyama; Eiichiro Nagata; Moataz M Gadalla; Solomon H Snyder; Makoto Suematsu
Journal: Proc Natl Acad Sci U S A Date: 2012-01-09 Impact factor: 11.205

6. Impact of early transcranial Doppler screening and intensive therapy on cerebral vasculopathy outcome in a newborn sickle cell anemia cohort.

Authors: Françoise Bernaudin; Suzanne Verlhac; Cécile Arnaud; Annie Kamdem; Sylvie Chevret; Isabelle Hau; Lena Coïc; Emmanuella Leveillé; Elisabeth Lemarchand; Emmanuelle Lesprit; Isabelle Abadie; Nadia Medejel; Fouad Madhi; Sophie Lemerle; Sandra Biscardi; Josiane Bardakdjian; Frédéric Galactéros; Martine Torres; Mathieu Kuentz; Christelle Ferry; Gérard Socié; Philippe Reinert; Christophe Delacourt
Journal: Blood Date: 2010-11-10 Impact factor: 22.113

Review 7. The significance of 2,3-DPG in red blood cell transfusions.

Authors: P R Sohmer; R B Dawson
Journal: CRC Crit Rev Clin Lab Sci Date: 1979-11

8. Regional oxygen extraction predicts border zone vulnerability to stroke in sickle cell disease.

Authors: Melanie E Fields; Kristin P Guilliams; Dustin K Ragan; Michael M Binkley; Cihat Eldeniz; Yasheng Chen; Monica L Hulbert; Robert C McKinstry; Joshua S Shimony; Katie D Vo; Allan Doctor; Hongyu An; Andria L Ford; Jin-Moo Lee
Journal: Neurology Date: 2018-03-02 Impact factor: 11.800

9. Hydroxyurea reduces cerebral metabolic stress in patients with sickle cell anemia.

Authors: Melanie E Fields; Kristin P Guilliams; Dustin Ragan; Michael M Binkley; Amy Mirro; Slim Fellah; Monica L Hulbert; Morey Blinder; Cihat Eldeniz; Katie Vo; Joshua S Shimony; Yasheng Chen; Robert C McKinstry; Hongyu An; Jin-Moo Lee; Andria L Ford
Journal: Blood Date: 2019-03-11 Impact factor: 22.113

10. Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia-TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial.

Authors: Russell E Ware; Barry R Davis; William H Schultz; R Clark Brown; Banu Aygun; Sharada Sarnaik; Isaac Odame; Beng Fuh; Alex George; William Owen; Lori Luchtman-Jones; Zora R Rogers; Lee Hilliard; Cynthia Gauger; Connie Piccone; Margaret T Lee; Janet L Kwiatkowski; Sherron Jackson; Scott T Miller; Carla Roberts; Matthew M Heeney; Theodosia A Kalfa; Stephen Nelson; Hamayun Imran; Kerri Nottage; Ofelia Alvarez; Melissa Rhodes; Alexis A Thompson; Jennifer A Rothman; Kathleen J Helton; Donna Roberts; Jamie Coleman; Melanie J Bonner; Abdullah Kutlar; Niren Patel; John Wood; Linda Piller; Peng Wei; Judy Luden; Nicole A Mortier; Susan E Stuber; Naomi L C Luban; Alan R Cohen; Sara Pressel; Robert J Adams
Journal: Lancet Date: 2015-12-06 Impact factor: 79.321

10 in total

6 in total

Brain O₂ reserve in sickle cell disease.

1. Red cell exchange transfusions lower cerebral blood flow and oxygen extraction fraction in pediatric sickle cell anemia.

2. Automated oxyhemoglobin dissociation curve construction to assess sickle cell anemia therapy.

3. White matter has impaired resting oxygen delivery in sickle cell patients.

4. Increased brain tissue oxygenation during arteriovenous malformation resection.

5. Hypoxic regulation of the cerebral microcirculation is mediated by a carbon monoxide-sensitive hydrogen sulfide pathway.

6. Impact of early transcranial Doppler screening and intensive therapy on cerebral vasculopathy outcome in a newborn sickle cell anemia cohort.

Review 7. The significance of 2,3-DPG in red blood cell transfusions.

8. Regional oxygen extraction predicts border zone vulnerability to stroke in sickle cell disease.

9. Hydroxyurea reduces cerebral metabolic stress in patients with sickle cell anemia.

10. Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia-TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial.

Review 1. The multifaceted role of ischemia/reperfusion in sickle cell anemia.

Review 2. Turning the Oxygen Dial: Balancing the Highs and Lows.

3. Sickle cell disease in the era of precision medicine: looking to the future.

4. Anemia Increases Oxygen Extraction Fraction in Deep Brain Structures but Not in the Cerebral Cortex.

5. Reduced global cerebral oxygen metabolic rate in sickle cell disease and chronic anemias.

6. Vascular Instability and Neurological Morbidity in Sickle Cell Disease: An Integrative Framework.